Diagnos Inc.ADK.V

Health Care · Health Care Equipment & Services · TSX-V · Canada · diagnos.com

DIAGNOS Inc. is a Canadian healthcare technology company that uses artificial intelligence for early detection of eye diseases. Its flagship product, the CARA System (Computer Assisted Retina Analysis), is a web-based tool that helps healthcare professionals detect diabetic retinopathy through AI-driven image processing of fundus photography. Founded in 1998 and headquartered in Brossard, Quebec, the company is seeking regulatory approvals in Canada (Health Canada), the United States (FDA), and Saudi Arabia (SFDA).

Key ratios

FCF / Sales

-5607.2%TTM

2025 -3517.5%2024 -1268.1%2023 -392.8%

ROA

-77.8%TTM

2025 -111.2%2024 -219.2%2023 -118.3%

ROE

-924.3%TTM

Recent news

DIAGNOS Receives Saudi FDA Medical Device License for CARA System, Bringing AI-Assisted Retinal Image Analysis to Saudi Arabia 2026-08-13 · GlobeNewswire CIRO Trade Resumption - ADK (Diagnos Inc.) 2026-07-27 · CNW DIAGNOS Receives Health Canada Medical Device Licence for CARA System 2026-07-27 · GlobeNewswire DIAGNOS Announces Grant of Stock Options and Adoption of Semi-Annual Reporting 2026-06-12 · GlobeNewswire DIAGNOS Announces the Engagement of IBN 2026-01-15 · Yahoo Finance

Track ADK.V in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer